Initially, Efemia will be available through Quintet’s online store. In addition to this, the distribution agreement with Invent Medic enables the company to secure agreements with pharmacy chains and other entities in the retail market. In this area, Quintet has a close collaboration with the leading Norwegian pharmacy chain Apotek1, that offers a wide selection of medical assistance products in their pharmacies.

“It is exciting that we are now able to launch Efemia in Norway before the end of the year together with Quintet, which will enable us to help many Norwegian women to live their life to the fullest. Quintet’s extensive experience in women’s health-focused assistance products, combined with strong relations with health care and retail entities, makes them an excellent partner for us, says Invent Medic’s CEO Karin Bryder.

“Efemia offers a unique and well-functioning solution for an important women’s health problem, making it a great fit in our product portfolio. We have already presented the product at events in Bergen and Oslo with a positive response, and we have good reason to expect that the product will be well received by women with SUI as well as relevant health care entities in Norway,” says Quintet’s CEO Hanna Solberg.

Around 500,000 women in Norway are estimated to be using some kind of protection against urine leakage and are thereby potential regular Efemia users. The new Efemia distributor Quintet is focusing on assistance products in incontinence, pain relief and sexual health, which makes the company well-experienced in Efemia’s product segment.

For more information please contact
Karin Bryder, CEO
Phone: +46 (0)723811710
E-mail: info@inventmedic.com

This information is information that Invent Medic Sweden AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on November 15, 2019.

About Invent Medic
Invent Medic Sweden AB (Invent Medic) is a Swedish company developing innovative products with the aim to improve women’s health and quality of life. The company’s products are to be safe, effective and easy to use. The finished women’s health products are sold through the company’s Arcamea brand. Invent Medic’s first product, Efemia, is a CE-certified and patented medical technology product used to reduce stress urinary incontinence (SUI) that was shown to reduce urine leakage with 77 percent during usage in a clinical study. The product is based on the same scientific principle as the TVT method, the premier surgical treatment for SUI. Invent Medic’s share is listed on the Spotlight Stock Market with the ticker symbol IMS, and the share’s ISIN code is SE0007603402. More information can be found at www.inventmedic.com and www.spotlightstockmarket.com.